We are live on ! Find out more
AMPE

Ampio Pharmaceuticals Inc.
AMPE

Delisted

AMPE was delisted on the 12th of April, 2024.

Back to rankings

95 hedge funds and large institutions have $1.77M invested in Ampio Pharmaceuticals Inc. in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 24 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

6,100% more call options, than puts

Call options by funds: $62K | Put options by funds: $1K

14% less funds holding

Funds holding: 111 → 95 (-16)

54% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 24

67% less capital invested

Capital invested by funds: $5.41M → $1.77M (-$3.64M)

75% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 20

Holders
95
Holders Change
-16
Holders Change %
-14.41%
% of All Funds
1.64%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
11
Reduced
24
Closed
20
Calls
$62K
Puts
$1K
Net Calls
+$61K
Net Calls Change
-$131K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$194K
2
SA
Shilanski & Associates
Alaska
+$109K
3
Millennium Management
Millennium Management
New York
+$76.7K
4
Two Sigma Advisers
Two Sigma Advisers
New York
+$38K
5
Man Group
Man Group
United Kingdom
+$21.8K

Top Sellers

Rank Fund Capital Flow
1
E
Ergoteles
New York
-$161K
2
Citadel Advisors
Citadel Advisors
Florida
-$77.4K
3
Renaissance Technologies
Renaissance Technologies
New York
-$73K
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$66K
5
AAP
Arax Advisory Partners
Colorado
-$62K
Name Holding Trade Value Shares
Change 		Change in
Stake
HSG
26
Helen Stephens Group
Texas
$7K – – –
AAP
27
Arax Advisory Partners
Colorado
$6K -$62K -1,769 -84%
Morgan Stanley
28
Morgan Stanley
New York
$6K -$23.7K -677 -66%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$6K – – –
NWM
30
Northcape Wealth Management
New York
$6K +$11.5K +327 New
CAPTRUST Financial Advisors
31
CAPTRUST Financial Advisors
North Carolina
$5K – – –
EWM
32
Empirical Wealth Management
Washington
$5K – – –
GIA
33
GHP Investment Advisors
Colorado
$5K – – –
UCFA
34
United Capital Financial Advisors
Texas
$5K – – –
LPL Financial
35
LPL Financial
California
$4K -$2.52K -72 -26%
CPIG
36
Chicago Partners Investment Group
Illinois
$4K – – –
DIA
37
Dana Investment Advisors
Wisconsin
$4K – – –
IWM
38
IHT Wealth Management
Illinois
$4K – – –
LP
39
LMR Partners
United Kingdom
$4K – – –
RJFSA
40
Raymond James Financial Services Advisors
Florida
$4K – – –
RJA
41
Raymond James & Associates
Florida
$4K +$595 +17 +8%
UBS Group
42
UBS Group
Switzerland
$4K +$3.05K +87 +57%
Goldman Sachs
43
Goldman Sachs
New York
$3K -$2.07K -59 -27%
FHA
44
Flagship Harbor Advisors
Massachusetts
$3K – – –
SBIA
45
Sheaff Brock Investment Advisors
Indiana
$3K – – –
Verition Fund Management
46
Verition Fund Management
Connecticut
$3K – – –
BCWM
47
Bartlett & Co Wealth Management
Ohio
$2.3K -$4.52K -129 -50%
BC
48
Bartlett & Co
Ohio
$2K -$4.52K -129 -50%
TSS
49
Two Sigma Securities
New York
$2K -$2.63K -75 -45%
ACM
50
Avalon Capital Management
California
$2K – – –
1
2
3 4 5

AMPE Hedge Fund Activity: Q3 2022 in Review

95 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q3 2022, worth a combined $1.77M — down 67% from $5.41M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of AMPE and 5 opened new positions — a net loss of 15 holders — while 24 trimmed existing stakes and 11 added.

The largest buyer was Vanguard Group, adding an estimated $194K. The largest seller was Ergoteles, exiting entirely with an estimated $161K sold.

  • 95 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q3 2022, down from 111 in Q2 2022.
  • Funds reported $1.77M of Ampio Pharmaceuticals Inc. stock for Q3 2022, down 67% quarter-over-quarter.
  • 5 funds opened new Ampio Pharmaceuticals Inc. positions in Q3 2022 and 20 closed out, a net change of -15 holders.
  • The largest Ampio Pharmaceuticals Inc. buyer in Q3 2022 was Vanguard Group, an estimated $194K added.
  • The largest Ampio Pharmaceuticals Inc. seller in Q3 2022 was Ergoteles, an estimated $161K sold.

Based on aggregated 13F filings for Q3 2022.